Clinical Benefits and Adverse Effects of Vonoprazan in Long-Term Maintenance Therapy

Bibliographic Details
Published in:	The Korean Journal of Gastroenterology
Main Author:	Jin Hee Noh
Format:	Article
Language:	English
Published:	Jin Publishing & Printing Co. 2025-01-01
Online Access:	https://www.kjg.or.kr/journal/view.html?uid=6086&vmd=Full

Similar Items

Vonoprazan-based Dual and Triple Therapy for Helicobacter pylori Eradication
by: Jin Hee Noh, et al.
Published: (2023-09-01)

The Potential Benefits of Vonoprazan as <i>Helicobacter pylori</i> Infection Therapy
by: Muhammad Miftahussurur, et al.
Published: (2020-09-01)

Vonoprazan-based therapy for eradication: experience and clinical evidence
by: Yuko Akazawa, et al.
Published: (2016-11-01)

Randomised clinical trial: 3-year interim analysis results of the VISION trial to evaluate the long-term safety of vonoprazan as maintenance treatment in patients with erosive oesophagitis
by: Ken Haruma, et al.
Published: (2023-05-01)

Step-Down Therapy Using Vonoprazan for Giant Gastric Polyps in Long-Term Proton Pump Inhibitor Administration
by: Daisuke Kikuchi, et al.
Published: (2025-03-01)

Rationale and design of the VISION study: a randomized, open-label study to evaluate the long-term safety of vonoprazan as maintenance treatment in patients with erosive esophagitis
by: Uemura N, et al.
Published: (2018-01-01)

Vonoprazan-associated infection: an analysis of the Japanese Adverse Drug Event Report and the FDA Adverse Event Reporting System
by: Mengling Ouyang, et al.
Published: (2024-07-01)

Incidence and type of adverse events in patients taking vonoprazan: A systematic review and meta-analysis
by: Wentao Xu, et al.
Published: (2023-04-01)

The efficacy and mechanism of vonoprazan-containing triple therapy in the eradication of Helicobacter pylori
by: Zinan Zhang, et al.
Published: (2023-05-01)

Vonoprazan on the Eradication of Helicobacter pylori Infection
by: Jiaming Huang, et al.
Published: (2023-03-01)

The role of vonoprazan in patients with erosive esophagitis
by: Mengyu Zhang, et al.
Published: (2022-09-01)

Efficacy of Step-Down Therapy Using Vonoprazan for Symptomatic Mild Reflux Esophagitis
by: Yorinari Ochiai, et al.
Published: (2024-01-01)

Fourteen-day vonoprazan-amoxicillin dual therapy versus 14-day bismuth-based quadruple therapy for treatment: a randomized clinical trial
by: Jin-Yan Zhang, et al.
Published: (2025-07-01)

Profound gastric mucosal changes and severe rebound acid hypersecretion after long‐term Vonoprazan use: A case report
by: Hiroko Suda, et al.
Published: (2025-04-01)

Long-term follow-up of patients developing gastric mucosal lesions after initiating the potassium-competitive acid blocker vonoprazan
by: Kimitoshi Kubo, et al.
Published: (2024-07-01)

Comment On: Vonoprazan on the Eradication of Helicobacter pylori Infection
by: Tolga Düzenli, et al.
Published: (2023-04-01)

Vonoprazan-associated Diffuse Gastric Mucosal Redness
by: Kenji Yamazaki, et al.
Published: (2022-01-01)

Effects of Simvastatin on the Metabolism of Vonoprazan in Rats Both in vitro and in vivo
by: Hong Y, et al.
Published: (2022-06-01)

Vonoprazan 10 mg or 20 mg vs. lansoprazole 15 mg as maintenance therapy in Asian patients with healed erosive esophagitis: A randomized controlled trial
by: Yinglian Xiao, et al.
Published: (2024-04-01)

Effect of Concomitant Use of Polaprezinc and Vonoprazan-Based Triple Therapy for <i>Helicobacter pylori</i> Eradication
by: Yuto Suzuki, et al.
Published: (2024-05-01)

Vonoprazan-amoxicillin combination therapy for Helicobacter pylori eradication: an umbrella review of meta-analyses
by: Saif Syed, et al.
Published: (2024-11-01)

The impact of the war on maintenance of long-term therapies in Ukraine
by: Nataliia Khanyk, et al.
Published: (2022-11-01)

RE: Comment On: Vonoprazan on the Eradication of Helicobacter pylori Infection
by: Jiaming Huang, et al.
Published: (2023-04-01)

Novel Cocrystals of Vonoprazan: Machine Learning-Assisted Discovery
by: Min-Jeong Lee, et al.
Published: (2022-02-01)

Efficacy of Vonoprazan-Tetracycline Dual Therapy in the Initial Treatment of Penicillin-Allergic Helicobacter pylori Infections
by: Younghee Choe
Published: (2024-12-01)

Vonoprazan versus Conventional Proton Pump Inhibitors Based Regimens in Helicobacter Pylori Eradication Therapy
by: Mohamed Ahmed, et al.
Published: (2023-10-01)

ADVERSE EFFECTS OF LONG-TERM CORTICOSTEROID THERAPY OF NEPHROTIC SYNDROME IN CHILDREN
by: T. L. Nastausheva, et al.
Published: (2017-08-01)

Comparison of vonoprazan and proton pump inhibitors for eradication of Helicobacter pylori
by: Satoshi Shinozaki, et al.
Published: (2016-05-01)

Real-world outcomes associated with vonoprazan-based proton pump inhibitor-based therapy for infection in Japan
by: Colin W. Howden, et al.
Published: (2023-05-01)

Sex-specific Differences in Response to First-line Helicobacter pylori Eradication Therapy with vonoprazan, amoxicillin, and clarithromycin
by: Yusaku Kajihara
Published: (2020-07-01)

Vonoprazan–minocycline dual therapy as a first-line treatment of infection compared with empirical bismuth-containing quadruple therapy
by: Meng Li, et al.
Published: (2025-08-01)

Seven‐day vonoprazan‐based triple therapy as first‐line Helicobacter pylori treatment in comparison with extended sequential therapy
by: Yu‐Tse Chiu, et al.
Published: (2023-02-01)

Benefits and challenges experienced by participants on long-term methadone maintenance treatment in China: a qualitative study
by: Xijia Tang, et al.
Published: (2024-01-01)

Long-term controlled antihypertensive therapy in Chernobyl liquidators, its effectiveness and benefits
by: I. I. Razdobreeva, et al.
Published: (2005-06-01)

Network meta-analysis of multiple doses of vonoprazan for the treatment of erosive esophagitis
by: Jie He, et al.
Published: (2023-07-01)

A Novel Approach to <i>H. pylori</i> Eradication: A Narrative Review of Vonoprazan-Based Therapies
by: Karolina Kornatowska, et al.
Published: (2025-09-01)

The efficacy and safety of vonoprazan–amoxicillin dual therapy in eradicating Helicobacter pylori: a systematic review and meta-analysis
by: Jia-Hui Feng, et al.
Published: (2023-08-01)

Effects of Rituximab Including Long-term Maintenance Therapy in Children with Nephrotic Syndrome in a Single Center of Korea
by: Seong Heon Kim, et al.
Published: (2018-04-01)

Long-term gastrointestinal adverse effects of doxycycline
by: Khalid Eljaaly, et al.
Published: (2023-02-01)

Reduction of gastro-intestinal adverse effect risk in long-term therapy with acetylsalicylic acid
by: E. Yu. Bulakhova, et al.
Published: (2010-08-01)